Gabriela Gruia - 15 Jul 2021 Form 4 Insider Report for TScan Therapeutics, Inc. (TCRX)

Role
Director
Signature
/s/ Gabriela Gruia
Issuer symbol
TCRX
Transactions as of
15 Jul 2021
Net transactions value
$0
Form type
4
Filing time
16 Jul 2021, 16:34:11 UTC
Next filing
02 Mar 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TCRX Stock Option (right to buy) Award $0 +9,146 $0.000000 9,146 15 Jul 2021 Voting Common Stock 9,146 $15.00 Direct F1
transaction TCRX Stock Option (right to buy) Award $0 +9,146 $0.000000 9,146 15 Jul 2021 Voting Common Stock 9,146 $15.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to this option will vest in 36 equal monthly installments upon the completion of each month of continuous service to the Issuer after May 4, 2021 .
F2 The shares subject to this option will vest in 12 equal monthly installments upon the completion of each month of continuous service to the Issuer after May 4, 2022.